Search Results - "Gummadi, Venkateshwar Rao"
-
1
Discovery of CA-4948, an Orally Bioavailable IRAK4 Inhibitor for Treatment of Hematologic Malignancies
Published in ACS medicinal chemistry letters (10-12-2020)“…Small molecule potent IRAK4 inhibitors from a novel bicyclic heterocycle class were designed and synthesized based on hits identified from Aurigene’s compound…”
Get full text
Journal Article -
2
Abstract 3646: Novel IRAK-4 inhibitors exhibit highly potent anti-proliferative activity in DLBCL cell lines with activating MYD88 L265P mutation
Published in Cancer research (Chicago, Ill.) (01-08-2015)“…Abstract Interleukin-1 Receptor Associated Kinase-4 (IRAK-4) is a serine/threonine protein kinase belonging to tyrosine like kinase (TLK) family. IRAK-4 is one…”
Get full text
Journal Article -
3
Abstract 4798: Efficacy and safety of highly selective novel IRAK4 inhibitors for treatment of ABC-DLBCL
Published in Cancer research (Chicago, Ill.) (15-07-2016)“…Abstract Interleukin-1 receptor associated kinases (IRAKs) are serine/threonine protein kinases belonging to the tyrosine-like kinase (TLK) family. IRAKs…”
Get full text
Journal Article -
4
Discovery of 7-azaindole based anaplastic lymphoma kinase (ALK) inhibitors: Wild type and mutant (L1196M) active compounds with unique binding mode
Published in Bioorganic & medicinal chemistry letters (01-09-2013)“…A novel series of 7-Azaindole derivatives have been identified as potent ALK inhibitors. Their synthesis and preliminary SAR are described. We have identified…”
Get full text
Journal Article -
5
Discovery of indole tetrafluorophenoxymethylketone-based potent novel small molecule inhibitors of caspase-3
Published in Organic and medicinal chemistry letters (16-07-2012)“…Background Caspase-3 inhibition has been demonstrated to be therapeutically effective in moderating excessive programmed cell death. Interest in caspase-3 as a…”
Get full text
Journal Article